FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)

View source ↗

Summary

FDA approved a supplemental application for insulin lispro (Humalog) submitted by Eli Lilly and Company. The approval confirms the supplemental action (AP) for …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• DILUENT (diluents)
• Humalog (insulin lispro)

Snippet

SUPPL AP for INSULIN LISPRO (INSULIN LISPRO)